INDIGO Biosciences Blog

Problems within Drug Discovery: Understanding Drug-Nutrient Interactions

October 14, 2021

0 Comments

Problems within Drug Discovery: Understanding Drug-Nutrient Interactions [What is a DNI and how Nuclear Receptor activation can be responsible]

Many compounds in the drug discovery process will be impacted by drug-nutrient interactions (DNI) and because of this, have the possibility to fail in clinical trials or have subsequent pharmacokinetic consequences. Xenobiotic nuclear receptors are known to play a significant role in DNI’s. Understanding what DNI’s are and knowing if they will modulate a drugs bioavailability can be important to success in clinical trials, as well as preventing potentially fatal drug-food and drug-herb interactions.

Read More

Nuclear receptors and the Microbiome: Does the road to happiness go through the gut?

September 14, 2021

0 Comments

Nuclear receptors and the Microbiome: Does the road to happiness go through the gut?

The microbiome or microbiota are the terms used for the microbes that live on and inside the human body. Trillions of microorganisms make up the microbiome including bacteria, fungi, parasites, and viruses. It is estimated that there are more microbial cells than human cells in the body and the majority of these microbes reside in the gut. There is a growing amount of research that has recently changed our understanding of the microbiome from being just a collection of symbiotic organisms to actively participating in a bidirectional communication system called the gut-brain axis.

Read More

CB1R & Drug Discovery: More Than a Feeling

August 17, 2021

0 Comments

CB1R & Drug Discovery: More Than a Feeling

The endocannabinoid system (ECS) is a complex cell-signaling system made up of cannabinoid receptors and the endogenous lipids called endocannabinoids that bind to them. This system was identified in the early 1990s with the cloning of the G-protein coupled receptors (GPCR) Cannabinoid Type 1 Receptor (CB1R) and Cannabinoid Type 2 Receptor (CB2R), as well as the identification of endogenous cannabinoids anandamide (AEA) and 2-arachidonoyl glycerol (2-AG).

Read More

Designing safer pharmaceutical leads through Discovery Toxicology

July 20, 2021

0 Comments

Traditional toxicology practices focus on characterizing a single compound in regulatory GLP toxicology studies over a long period of time directly prior to clinical phase 1 trials. By this time, large amounts of time and resources have been invested into finding a single drug candidate. If a liability is found, researchers are left deciding if the benefits outweigh potential liabilities or if they need to start over, having spent time and resources on that single candidate. With late-stage failures due to toxicity continuing to be a primary cause for compound attrition, incorporating predictive in vitro testing into the discovery process is essential for those working in drug discovery.

Read More

How Nuclear Receptor Profiling Can Determine the Fate of Your Compounds

June 2, 2021

0 Comments

To Be or Not to Be: How Nuclear Receptor Profiling Can Determine the Fate of Your Compounds

Nuclear receptors act as transcription factors that mediate the effects of hormones, drugs, and other xenobiotics by regulating the expression of specific genes involved in many cellular functions including development, reproduction, and metabolism. The target gene and protein expression patterns of nuclear receptors and their physiological effects create a network that can be monitored by multimodal approaches, such as systems biology. Therefore, defining the biological niche of each nuclear receptor and understanding their overlapping pathways and functions can provide value to discovery researchers when evaluating a potential compound’s promise and liabilities.

Read More

Bioluminescence vs. Fluorescence: Which should I choose to assay my compounds?

May 13, 2021

0 Comments

Bioluminescence vs. Fluorescence: Which should I choose to assay my compounds?

When looking to perform in vitro cell-based target validation, pathway analysis, and compound screening there are several types of assays to choose from. One question you might ask when evaluating different cell-based reporter assay technologies is, what is better for my research: an assay system that uses fluorescence or an assay system that utilizes bioluminescence? Both technologies can provide researchers with valuable data so let us weigh their advantages and disadvantages.

Read More

What is the Nuclear Receptor Superfamily?

April 7, 2021

0 Comments

What is the Nuclear Receptor Superfamily?

The nuclear receptor superfamily is a group of intracellular transcription factors that directly regulate gene expression in response to lipophilic molecules. These receptors are found in metazoan organisms such as nematodes, insects, and vertebrates. Nuclear receptors affect a wide variety of physiologic functions including development, reproduction, and metabolism and are associated with diseases such as Alzheimer’s, cancer, and diabetes.

Read More

Common Ortholog Models & Their Use in Drug Development Research

March 11, 2021

0 Comments

An animal model is a non-human species that has been widely studied and used during research to help understand biological processes in a laboratory setting. The use of animal models as human surrogates has provided a great deal of information about physiology and disease with over 150 Nobel Prizes awarded in physiology or medicine to professionals utilizing animal models for their research.

The primary reason for the use of animal models is the evolutionary principle that all organisms share some degree of relatedness and genetic similarity. Vertebrate models in particular are useful as human surrogates in drug discovery and medical research due to their more common ancestry. Though there are many vertebrates that could be used, a few are more common in research than others.

Read More

Growth Factor Receptors and Oncology

February 9, 2021

0 Comments

Growth factors are proteins that stimulate the growth of specific tissues. They bind to cells by growth factor receptors, activating cellular proliferation and differentiation. This activation of growth factor receptors creates a short, time-limited signal, which causes different parts of cellular proliferation and differentiation such as mitosis, clonal expansion, gene regulation, and cell apoptosis. While growth factor receptors operate on different cell types, their signal pathways often overlap, which makes them important targets for oncology research.

Read More

Growth Factors: A Brief Overview

January 19, 2021

0 Comments

Growth Factors: A Brief Overview

What are Growth Factors and How Do They Work?

First discovered by Rita Levi-Montalcini, growth factors are compact polypeptides, that bind to transmembrane receptors harboring kinase activity, to stimulate specific combinations of intracellular signaling pathways. The intracellular signaling pathways that are activated by growth factors are mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K), phospholipase C-γ, and transcription factors like the signal transducers and activators of transcription (STATs) or SMAD proteins. This activation of growth factor receptors creates a short, time-limited signal, which causes different parts of cellular proliferation and differentiation such as mitosis, clonal expansion, gene regulation, and cell apoptosis. Unlike hormones which have a wider systemic influence, growth factors usually transmit signals between cells to modulate their activity. They act as chemical messengers, communicating with different cells to stimulate growth. Depending on their function, growth factors can produce endocrine, paracrine, autocrine, or juxtracrine responses in cells.

Read More


INDIGO Biosciences - The right partner for all your discovery and toxicology needs.

Subscribe to Our Blog

Lists by Topic